Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients
Open Access
- 28 September 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 65 (12) , 2505-2513
Abstract
Patients with autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy (APECED, APS-I) suffer from chronic candidosis caused mainly by Candida albicans, and repeated courses of azole antifungals have led to the development of resistance in the APECED patient population in Finland. The aim of our study was to address whether the patients are persistently colonized with the same or genetically closely related strains, whether epidemic strains are present and which molecular mechanisms account for azole resistance. Sets of C. albicans (n = 19) isolates from nine APECED patients reported with decreased susceptibility to fluconazole isolated up to 9years apart were included. The strains were typed by multilocus sequence typing. CDR1/2, MDR1 and ERG11 mRNA expression was analysed by northern blotting and Cdr1, Cdr2 and Mdr1 protein expression by western blotting, and TAC1 and ERG11 genes were sequenced. All seven patients with multiple C. albicans isolates analysed were persistently colonized with the same or a genetically closely related strain for a mean of 5 years. All patients were colonized with different strains and no epidemic strains were found. The major molecular mechanisms behind the azole resistance were mutations in TAC1 contributing to overexpression of CDR1 and CDR2. Six new TAC1 mutations were found, one of which (N740S) is likely to be a gain-of-function mutation. Most isolates were found to have gained multiple TAC1 and ERG11 point mutations. Despite clinically successful treatment leading to relief of symptoms, colonization by C. albicans strains is persistent within APECED patients. Microevolution and point mutations occur within strains, leading to the development of azole-resistant isolates.Keywords
This publication has 34 references indexed in Scilit:
- Candida albicans isolates from APECED patients show decreased susceptibility to miconazoleInternational Journal of Antimicrobial Agents, 2009
- Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type IJournal of Internal Medicine, 2009
- Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasisDiagnostic Microbiology and Infectious Disease, 2008
- Decreased susceptibility of Candida albicans to azole antifungals: a complication of long-term treatment in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patientsJournal of Antimicrobial Chemotherapy, 2007
- Molecular epidemiology of long-term colonization of Candida albicans strains from HIV-infected patientsEpidemiology and Infection, 2005
- Evaluation of fluconazole resistance mechanisms in candida albicans clinical isolates from HIV-infected patients in BrazilDiagnostic Microbiology and Infectious Disease, 2004
- Resistance Mechanisms in Clinical Isolates of Candida albicansAntimicrobial Agents and Chemotherapy, 2002
- Chronic mucocutaneous candidiasis. II. Class and subclass of specific antibody responses in vivo and in vitroClinical and Experimental Immunology, 1996
- Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transportersAntimicrobial Agents and Chemotherapy, 1995
- An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21Nature Genetics, 1994